GlassScriptPhysician profile
Paul Lucas
NPI 1528036589
$26,606.41
in general payments reported to CMS, 2019-2025
43 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,183 · 2020: $960 · 2021: $15K · 2022: $5,729 · 2023: $890 · 2024: $572 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17,287.39 | 2019-2022 | |
| Medtronic, INC. | $1,287.45 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System, Hawkone |
| Silk Road Medical, INC. | $1,028.95 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Sirtex Medical INC | $632.91 | 2019-2024 | Sir-Spheres Microspheres |
| Philips North America LLC | $622.70 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $579.68 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $551.15 | 2022-2025 | General - Vascular Intervention, Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cordis US Corp. | $447.57 | 2021-2024 | S.M.A.R.T., Brite Tip Radianz |
| Bard Peripheral Vascular, INC. | $409.72 | 2019-2023 | Rotarexs 6 F X 135 Cm, Venovo |
| Mindray Ds USA, INC. | $398.94 | 2021-2025 | Te7 Max, Te X |
| Medtronic Vascular, INC. | $365.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $347.28 | 2019-2024 | Xarelto |
| Abbvie INC. | $251.61 | 2021-2024 | |
| Aroa Biosurgery Incorporated | $225.07 | 2020-2022 | |
| Cook Medical LLC | $201.27 | 2019-2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $177.92 | 2019-2025 | |
| Inari Medical, INC. | $173.00 | 2020-2022 | |
| Surmodics, INC. | $170.11 | 2022-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Organogenesis INC. | $160.70 | 2019-2025 | Puraply, Cygnus Dual, Apligraf |
| Penumbra, INC. | $147.42 | 2022 | |
| Collaborative Care Diagnostics, LLC | $135.06 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $131.59 | 2019-2020 | |
| Smith+Nephew, INC. | $130.98 | 2019-2024 | Collagenase Santyl |
| Tactile Systems Technology INC | $115.90 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Allergan, INC. | $106.72 | 2019-2020 | |
| Cashflow Solutions, LLC | $93.48 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Baxter Healthcare | $51.88 | 2019-2023 | Biosurgery - Guard |
| Convatec INC. | $48.18 | 2021-2022 | |
| Biocomposites INC | $37.38 | 2024 | |
| Kerecis Limited | $33.91 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $30.39 | 2019 | |
| Amgen INC. | $28.76 | 2024 | Repatha |
| Portola Pharmaceuticals, LLC | $27.68 | 2019 | |
| Cardiovascular Systems INC. | $26.98 | 2020 | |
| Mimedx Group, INC. | $24.95 | 2025 | |
| Solventum Corporation | $20.81 | 2025 | Activ.A.C., Prevena |
| Regeneron Healthcare Solutions, INC. | $15.82 | 2019 | |
| Sanara Medtech INC. | $15.78 | 2022 | |
| Ovik Health, LLC | $15.34 | 2023 | |
| Medline Industries LP | $15.03 | 2019 | |
| Lemaitre Vascular, INC. | $14.08 | 2025 | Artegraft Vascular Graft |
| Medela LLC | $11.53 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $8.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.